|
Orthologous residues
|
|
ELK1 (human): S389‑p, ELK1 (mouse): S390‑p, ELK1 (rat): S388‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
MCF-7 (breast cell)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
TGF-beta
|
|
|
|
increase
|
|
|
estrogen
|
|
|
|
increase
|
|
|
ICI 182,780
|
estrogen
|
|
|
inhibit treatment-induced increase
|
|
|
PD98059
|
estrogen
|
|
|
inhibit treatment-induced increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
transcription, altered
|